Bilirubin levels and the burden of coronary atherosclerosis in patients with STEMI

Angiology

Volumn 64, Issue 3, 2013, Pages 200-204

  Sahin, Omer ^a   Akpek, Mahmut ^a   Elcik, Deniz ^a   Karadavut, Serhat ^a   Simsek, Vedat ^b   Tulmac, Murat ^b   Orscelik, Ozcan ^a   Calapkorur, Bekir ^a   Ergin, Ali ^a   Kaya, Mehmet G ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

bilirubin; ST elevated myocardial infarction; SYNTAX score

Indexed keywords

BILIRUBIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIAC PATIENT; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNTAX SCORE;

AGED; BILIRUBIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION;

EID: 84876006696     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319712440619     Document Type: Article

References (29)

1. Akpek M, Elcik D, Kalay N, et al. The prognostic value of serum gamma glutamyl transferase activity on admission in patients with STEMI undergoing primary PCI. Angiology. 2013 ; 63 (8). 579-585
2. Akpek M, Kaya MG, Uyarel H, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis. 2011 ; 219 (1). 334-341
3. Maines MD, Trakshel GM, Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem. 1986 ; 261 (1). 411-419
4. Breimer LH, Mikhailidis DP. Could carbon monoxide and bilirubin be friends as well as foes of the body?. Scand J Clin Lab Invest. 2010 ; 70 (1). 1-5
5. Okuhara K, Kisaka T, Ozono R, et al. Change in bilirubin level following acute myocardial infarction is an index for heme oxygenase activation. South Med J. 2010 ; 103 (9). 876-881
6. Serruys PW, Morice MC, Kappetein AP, et al. SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypasses grafting for severe coronary artery disease. N Engl J Med. 2009 ; 360 (10). 961-972
7. Van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol. 2009 ; 135 (1). 60-65
8. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009 ; 5 (1). 50-56
9. Wykrzykowska JJ, Garg S, Girasis C, et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol. 2010 ; 56 (4). 272-277
10. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005 ; 1 (2). 219-227
11. Leaman DM, Brower RW, Meester GT, et al. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation. 1981 ; 63 (2). 285-299
12. Heistad DD, Wakisaka Y, Miller J, et al. Novel aspects of oxidative stress in cardiovascular diseases. Circ J. 2009 ; 73 (2). 201-207
13. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994 ; 344 (8925). 793-795
14. Kaya MG, Uyarel H, Akpek M, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012 ; 109 (4). 486-491
15. Darley-Usmar V, Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res. 1996 ; 13 (5). 649-662
16. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998 ; 98 (15). 1487-1494
17. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol. 1998 ; 18 (1). 100-107
18. Shibahara S. The heme oxygenase dilemma in cellular homeostasis: new insights for the feedback regulation of heme catabolism. Tohoku J Exp Med. 2003 ; 200 (4). 167-186
19. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000 ; 6 (4). 422-428
20. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987 ; 235 (4792). 1043-1046
21. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 1994 ; 269 (24). 16712-1619
22. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem. 2000 ; 46 (11). 1723-1727
23. Nakayama M, Takahashi K, Komaru T, et al. Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2001 ; 21 (8). 1373-1377
24. Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal. 2004 ; 6 (5). 841-849
25. Rigato I, Ostrow JD, Tiribelli C. Bilirubin and the risk of common non-hepatic diseases. Trends Mol Med. 2005 ; 11 (6). 277-283
26. Wu TW, Wu J, Li RK, Mickle D, Carey D. Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochem Cell Biol. 1991 ; 69 (10-11). 683-688
27. Yano Y, Ozono R, Oishi Y, et al. Genetic ablation of the transcription repressor Bach1 leads to myocardial protection against ischemia/reperfusion in mice. Genes Cells. 2006 ; 11 (7). 791-803
28. Melo LG, Agrawal R, Zhang L, et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation. 2002 ; 105 (5). 602-607
29. Yet SF, Tian R, Layne MD, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. 2001 ; 89 (2). 168-173